Market by Component (Storage, Transportation, Monitoring components), Pharma Type (Branded Drugs, Generic Drugs, OTC), Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas), Logistics Type (Non-Cold Chain Logistics, Cold Chain Logistics) and Country Outlook | Forecast 2024-2032
According to Triton’s research report, the Asia-Pacific pharmaceutical logistics market is estimated to progress at a CAGR of 8.45% during the forecast period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The Asia-Pacific region, characterized by its significant aging population and rising prevalence of chronic diseases, is witnessing substantial growth in its pharmaceutical logistics market. This growth is fueled by increased healthcare spending and government investments in R&D, particularly in emerging markets like China and India. For instance, China’s healthcare expenditure witnessed significant growth in 2021, recording double the expenditure from 2015 at around $1.2 trillion.
Further, India’s National Health Policy of 2017 aims to increase public health expenditure to 2.5% of the GDP by 2025, emphasizing improvements in primary and preventive care. Heightened health awareness and improved life expectancy contribute to the expanding pharmaceutical industry, thereby increasing the demand for efficient pharmaceutical logistics services.
The countries analyzed in this region include:
China leads the regional market, recording $7394.62 million in 2023
Since joining the World Trade Organization, China’s pharmaceutical industry has advanced significantly. In 2021, Chinese pharma companies saw a remarkable 18.7% year-on-year revenue increase, the highest in five years. This has boosted the demand for pharmaceutical logistics services.
There is also a notable trend among large local companies to upgrade their blister packaging equipment. This shift has made China a major market for high-speed blister packaging machines, which has significantly boosted the operations of pharmaceutical logistics companies.
Pharmaceutical distribution companies have improved their logistics capacities, enabling better drug distribution services in urban areas. For instance, Shanghai has witnessed developments with the establishment of advanced logistics centers to handle varied pharmaceutical products, including temperature-sensitive drugs, leveraging advanced technology for storage and distribution.
Market Forecast for Japan & India
Japan hosts one of the world’s largest pharmaceutical sectors, with healthcare expenditures comprising about 11.5% of its GDP in 2022, as per the World Bank. Further, OECD data suggests that health expenditure was around $5251 in 2022. As of 2023, the pharmaceutical sector, including both prescription and non-prescription drugs, is valued at around $107 billion. Notably, anti-tumor agents have been the leading category of medications in Japan. Hence, the rise in healthcare spending and the pharmaceutical sector drives the demand for pharmaceutical logistics services.
India stands as the leading supplier of generic medicines, providing around 20% of the global supply. In March 2022, pharmaceutical exports from India reached around $2.4 billion. Key segments of India’s pharmaceutical industry include generics, active pharmaceutical ingredients (APIs), vaccines, over-the-counter (OTC) medicines, biosimilars, and custom research manufacturing (CRM). Drug formulations and biologics dominate its pharmaceutical exports, comprising about 75% of the total. Such dominance supports India’s fast growth in the pharmaceutical logistics market.
The market is segmented in terms of logistics type, component, pharma type, and therapy area. The logistics type further includes non-cold and cold chain logistics.
Non-cold chain logistics in the pharmaceutical industry involves the storage and transportation of products that do not require temperature control. These pharmaceuticals are stable at room temperature, generally between 20°C and 25°C. Examples include over-the-counter medications, generic drugs, and certain prescription medicines, which can be safely stored and transported at these ambient temperatures.
The notable firms in the pharmaceutical logistics market include FedEx Corporation, Marken, SEKO Logistics, Kuehne + Nagel, Medline Industries LP, and United Parcel Service (UPS).
SEKO Logistics offers supply chain solutions in logistics, transportation, forwarding, and warehousing. The company offers innovative IT systems for seamless information flow and supply chain transparency. The company is renowned for its reliable, time-sensitive healthcare logistics services, catering to biotechnology, clinical trials, medical device manufacturers, and pharmaceutical firms. It specializes in the transportation of surgical, diagnostic, medical, and imaging equipment, as well as pharmaceutical products and clinical trial samples. SEKO operates through 120 offices across 40 countries, demonstrating its extensive global reach.
Latest from the Company:
In November 2023, SEKO Logistics established operations in India and Malaysia, expanding its positioning in Southeast Asia. The company stated its major focus to be freight forwarding and out of gauge cargo handling.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the smart meter data management market revenue growth in the Asia-Pacific and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the APAC pharmaceutical logistics market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL LOGISTICS MARKET
2.1.1. IMPACT
OF COVID-19
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. LOGISTICS
TYPE
2.3.2. SERVICES
OFFERED
2.3.3. MODE
OF TRANSPORTATION
2.3.4. APPLICATION
2.3.5. REGULATORY
COMPLIANCE
2.3.6. TECHNOLOGICAL
CAPABILITIES
2.3.7. COST
2.3.8. RELIABILITY
2.3.9. AGILITY
2.4. VALUE
CHAIN ANALYSIS
2.4.1. MANUFACTURING
2.4.2. STORAGE
2.4.3. TRANSPORTATION
2.4.4. DISTRIBUTION
2.4.5. MONITORING
COMPONENTS
2.4.6. CONSUMPTION
2.5. REGULATORY
OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
& PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8. MARKET
DRIVERS
2.8.1. ESCALATING
DEMAND FOR TEMPERATURE-REGULATED SOLUTIONS
2.8.2. EXPANDING
OCEAN FREIGHT SERVICES
2.8.3. INCREASING
CONSUMER INCLINATION TOWARDS OVER-THE-COUNTER MEDICATIONS
2.9. MARKET
CHALLENGES
2.9.1. NECESSITY
FOR REAL-TIME TRANSPARENCY AND DEPENDABILITY
2.9.2. STRINGENT
REGULATORY MANDATES
2.10. MARKET
OPPORTUNITIES
2.10.1. RISING
OPPORTUNITIES IN CELL & GENE THERAPY LOGISTICS DUE TO INCREASED DEMAND
2.10.2. DIGITAL
TRANSFORMATION PAVING THE WAY FOR ADVANCEMENTS IN PHARMACEUTICAL LOGISTICS
2.10.3. GROWING
DEMAND FOR CLINICAL TRIAL LOGISTICS
2.11. ANALYST
PERSPECTIVE
3. ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET - BY COMPONENT
3.1. STORAGE
3.2. TRANSPORTATION
3.3. MONITORING
COMPONENTS
4. ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET - BY PHARMA TYPE
4.1. BRANDED
DRUGS
4.2. GENERIC
DRUGS
4.3. OTC
5. ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET - BY LOGISTICS TYPE
5.1. NON-COLD
CHAIN LOGISTICS
5.2. COLD
CHAIN LOGISTICS
6. ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET - BY THERAPY AREA
6.1. COMMUNICABLE
DISEASES
6.2. ONCOLOGY
6.3. DIABETES
6.4. CARDIOVASCULAR
DISEASES
6.5. AUTOIMMUNE
DISEASES
6.6. NEUROLOGICAL
DISORDERS
6.7. PAIN
MANAGEMENT
6.8. RESPIRATORY
DISEASES
6.9. OTHER
THERAPY AREAS
7. ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET – BY COUNTRY OUTLOOK
7.1. CHINA
7.1.1. CHINA
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2. JAPAN
7.2.1. JAPAN
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3. INDIA
7.3.1. INDIA
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.4. ASEAN
COUNTRIES
7.4.1. ASEAN
COUNTRIES PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5. AUSTRALIA
& NEW ZEALAND
7.5.1. AUSTRALIA
& NEW ZEALAND PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.6. SOUTH
KOREA
7.6.1. SOUTH
KOREA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.7. REST
OF ASIA-PACIFIC
7.7.1. REST
OF ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AGILITY
LOGISTICS
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. AP
MOLLER – MAERSK
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. CARDINAL
HEALTH INC
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. CENCORA
(AMERISOURCEBERGEN)
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. CEVA
LOGISTICS
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. DB
SCHENKER
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. DEUTSCHE
POST AG
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. DSV
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. FEDEX
CORPORATION
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. KUEHNE
+ NAGEL
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. MARKEN
(ACQUIRED BY UPS)
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. 8KEY
CHALLENGES
8.12. MEDLINE
INDUSTRIES LP
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SEKO
LOGISTICS
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
8.14. UNITED
PARCEL SERVICE (UPS)
8.14.1. OVERVIEW
8.14.2. PORTFOLIO
8.14.3. KEY
STRENGTHS
8.14.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE 2: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, FORECAST YEARS, 2024-2032
(IN $ MILLION)
TABLE 3: LIST OF CONTRACTS &
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: ASIA-PACIFIC PHARMACEUTICAL
LOGISTICS MARKET, BY COMPONENT, 2023 & 2032 (IN %)
FIGURE 5: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $
MILLION)
FIGURE 8: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2023 & 2032 (IN %)
FIGURE 9: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2023 & 2032 (IN %)
FIGURE 13: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 14: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 15: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL BY THERAPY AREA, 2023 &
2032 (IN %)
FIGURE 16: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 17: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 20: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 21: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $
MILLION)
FIGURE 22: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 24: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $
MILLION)
FIGURE 25: ASIA-PACIFIC
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 26: CHINA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 27: JAPAN
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 28: INDIA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 29: ASEAN COUNTRIES
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 30: AUSTRALIA & NEW
ZEALAND PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: SOUTH KOREA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 32: REST OF
ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)